Home » All » Stock Forecast » 4D Molecular Therapeutics Inc. Common Stock Forecast

4D Molecular Therapeutics Inc. Common Stock Forecasts for Tomorrow, Week, Month and 5 Years

Updated: April 22 · 2026 at 07:03 UTC

From

▼ -3.08%Market Cap $498.26M · Technical analysis Bearish · Focus area Price + volatility

Forecast Summary

Timeframe	Predicted Price	Past	Historical	Insight
Tomorrow	$9.88 ▲ +1.24%	Yesterday	$9.71 ▼ -0.52%	Tomorrow's 4D Molecular Therapeutics Inc. Common Stock (FDMT) setup is anchored to $9.76 and targets $9.88 (+1.24%). The near-term read is upside; watch $10.05 / $9.47 because daily realized volatility is about 6.38%.
Tomorrow's 4D Molecular Therapeutics Inc. Common Stock (FDMT) setup is anchored to $9.76 and targets $9.88 (+1.24%). The near-term read is upside; watch $10.05 / $9.47 because daily realized volatility is about 6.38%.
Week	$10.14 ▲ +3.85%	Last Week	$9.60 ▼ -1.62%	The 7-day 4D Molecular Therapeutics Inc. Common Stock model moves from $9.60 to $10.14 (+3.85%). It gives upside momentum context for this stock, so breaks around $10.05 / $9.47 matter more than a single tick.
The 7-day 4D Molecular Therapeutics Inc. Common Stock model moves from $9.60 to $10.14 (+3.85%). It gives upside momentum context for this stock, so breaks around $10.05 / $9.47 matter more than a single tick.
Month	$10.56 ▲ +8.20%	Last Month	$9.42 ▼ -3.44%	The 1-month 4D Molecular Therapeutics Inc. Common Stock target is $10.56 (+8.20%), compared with the live reference near $9.76. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
The 1-month 4D Molecular Therapeutics Inc. Common Stock target is $10.56 (+8.20%), compared with the live reference near $9.76. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
Year	$11.20 ▲ +14.72%	Last Year	$9.16 ▼ -6.18%	The 1-year 4D Molecular Therapeutics Inc. Common Stock scenario points to $11.20 (+14.72%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
The 1-year 4D Molecular Therapeutics Inc. Common Stock scenario points to $11.20 (+14.72%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5 Years	$12.69 ▲ +30.00%	5 Years Ago	$8.53 ▼ -12.60%	The 5-year 4D Molecular Therapeutics Inc. Common Stock view is $12.69 (+30.00%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
The 5-year 4D Molecular Therapeutics Inc. Common Stock view is $12.69 (+30.00%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Tomorrow$9.88▲ +1.24%

Yesterday$9.71▼ -0.52%

Tomorrow's 4D Molecular Therapeutics Inc. Common Stock (FDMT) setup is anchored to $9.76 and targets $9.88 (+1.24%). The near-term read is upside; watch $10.05 / $9.47 because daily realized volatility is about 6.38%.

Week$10.14▲ +3.85%

Last Week$9.60▼ -1.62%

The 7-day 4D Molecular Therapeutics Inc. Common Stock model moves from $9.60 to $10.14 (+3.85%). It gives upside momentum context for this stock, so breaks around $10.05 / $9.47 matter more than a single tick.

Month$10.56▲ +8.20%

Last Month$9.42▼ -3.44%

The 1-month 4D Molecular Therapeutics Inc. Common Stock target is $10.56 (+8.20%), compared with the live reference near $9.76. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.

Year$11.20▲ +14.72%

Last Year$9.16▼ -6.18%

The 1-year 4D Molecular Therapeutics Inc. Common Stock scenario points to $11.20 (+14.72%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.

5 Years$12.69▲ +30.00%

5 Years Ago$8.53▼ -12.60%

The 5-year 4D Molecular Therapeutics Inc. Common Stock view is $12.69 (+30.00%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Risk notice:This forecast is informational only, not financial advice; accuracy depends on volatility, liquidity, macro events, and other external factors.

Price Chart

HistoricalForecastBullishBearish

Technical Analysis

Neutral

Bullish

Neutral

Bearish

Key Indicators

Indicator	Value	Signal
Price	$9.76	Mid
Daily Change	-3.08%	Below
Volatility Cap	20.0%	Mid
Confidence	64%	Above
Data Source	nasdaq-screener	Mid

Historical Data

Current$9.76

Daily Change-3.08%

Market Cap$498.26M

Sourcenasdaq-screener

Current	$9.76	Daily Change	-3.08%
Market Cap	$498.26M	Source	nasdaq-screener

Support & Resistance Levels

$9.47Support 1

$9.76Current

$10.05Resistance 1

Support and resistance are estimated from the trusted current price until deeper historical data is available.

Price Milestones

Key levels & historical context

Current$9.76Live reference price

Used as the anchor for generated forecast calculations.

Next Month$10.56Model projection+8.20%

Directional scenario based on capped drift.

Forecast Accuracy

How our model has performed

64%

Directional

Generated market-data forecast

This page uses live catalog market data and conservative volatility caps. It is informational, not financial advice.

📊

Our algorithm is re-calibrated weekly using the latest price action, volatility regime, and indicator signals. Accuracy varies by timeframe — short-term momentum is more reliable than long-term projections.

Short term

64%

Direction confidence

Long term

Lower

Forecast uncertainty rises with horizon

Investment Scenarios

If you invest $1,000 in FDMT today

Bullish Scenario

$10.25

+5.00% from current

Target Price$10.25

ScenarioUpside momentum

Probability56%

Base Scenario

$10.56

+8.20%

Target Price$10.56

ScenarioCapped drift

Probability64%

Bearish Scenario

$9.27

-5.00% from current

Target Price$9.27

ScenarioVolatility drawdown

Probability36%

Basis: Scenario model combines current spot price, recent market direction, and conservative asset-class volatility caps.

Forecast Factors

Market Structure

Price structure reflects the latest momentum regime and support/resistance interaction.

Momentum Bullish · 67/100

24H drift+1.24%

7D drift+3.85%

30D drift+8.20%

Technical Signals

Signals combine RSI, MACD, and moving average stacks to estimate short-term direction.

Mixed — Watching · 50/100

RSIn/a

MACDn/a

MA stackn/a

Macro Context

Rates, dollar strength, and cross-asset risk appetite influence medium-term paths.

Risk-On Tentative · 65/100

1M outlook+8.20%

1Y outlook+14.72%

5Y outlook+30.00%

Frequently Asked Questions

Q What is the 4D Molecular Therapeutics Inc. Common Stock (FDMT) forecast for tomorrow?

Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), 4D Molecular Therapeutics Inc. Common Stock is projected near $9.88 versus the current reference around $9.76. That implies a modeled move of +1.24% over the next day, with realized prices still sensitive to intraday volatility.

Q What does the 7-day stock outlook suggest for FDMT?

The weekly 4D Molecular Therapeutics Inc. Common Stock model points to $10.14, which maps to an expected drift of +3.85% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.

Q How should I read the 4D Molecular Therapeutics Inc. Common Stock 1-month and 1-year targets?

The 4D Molecular Therapeutics Inc. Common Stock 1-month target is $10.56 (+8.20%), while the 1-year target is $11.20 (+14.72%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.

Q Why does the 4D Molecular Therapeutics Inc. Common Stock 5-year scenario differ from short-term rows?

The 4D Molecular Therapeutics Inc. Common Stock long-horizon scenario sits near $12.69 with a modeled change of +30.00%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.

Q Where are FDMT support and resistance zones right now?

For 4D Molecular Therapeutics Inc. Common Stock, nearest resistance is around $9.47, while nearest support is around $10.05. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.

Q How fresh is the 4D Molecular Therapeutics Inc. Common Stock market snapshot?

The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.